ClinicalTrials.gov record
Recruiting Phase 2 Interventional

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

ClinicalTrials.gov ID: NCT06967805

Public ClinicalTrials.gov record NCT06967805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Study identification

NCT ID
NCT06967805
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mediar Therapeutics
Industry
Enrollment
164 participants

Conditions and interventions

Interventions

  • MTX-463 Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 4, 2025
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027
Last update posted
May 5, 2026

2025 – 2027

United States locations

U.S. sites
26
U.S. states
22
U.S. cities
26
Facility City State ZIP Site status
WISPer Site in Birmingham, AL Birmingham Alabama 35233 Recruiting
WISPer site in Phoenix, AZ Phoenix Arizona 85032 Recruiting
WISPer Site in Los Angeles, CA Los Angeles California 90033 Recruiting
WISPer site in Newport Beach, CA Newport Beach California 92663 Recruiting
WISPer Site in Palm Springs, CA Palm Springs California 92203 Recruiting
WISPer Site in Denver, CO Denver Colorado 80206 Recruiting
WISPer site in Loxahatchee, FL Loxahatchee Groves Florida 33470 Recruiting
WISPer Site in Atlanta, GA Atlanta Georgia 30322 Recruiting
WISPer site in Champaign, IL Champaign Illinois 61822 Recruiting
WISPer site in Kansas City, KS Kansas City Kansas 66160 Recruiting
WISPer Site in Louisville, KY Louisville Kentucky 40202 Recruiting
WISPer site in Shreveport, LA Shreveport Louisiana 71103 Recruiting
WISPer Site in Baltimore, MD Baltimore Maryland 21224 Recruiting
WISPer Site in Boston, MA Boston Massachusetts 02114 Recruiting
WISPer Site in Ann Arbor, MI Ann Arbor Michigan 48209 Recruiting
WISPer Site in Detroit, MI Detroit Michigan 48202 Recruiting
WISPer site in New York, NY New York New York 10032 Recruiting
WISPer Site in Durham, NC Durham North Carolina 27710 Recruiting
WISPer site in Greensboro, NC Greensboro North Carolina 27403 Recruiting
WISPer site in Oklahoma City, OK Oklahoma City Oklahoma 73104 Recruiting
WISPer Site in Pittsburg, PA Pittsburgh Pennsylvania 15213 Recruiting
WISPer Site in Charleston, SC Charleston South Carolina 29425 Recruiting
WISPer Site in Nashville, TN Nashville Tennessee 37204 Recruiting
WISPer site in Dallas, TX Dallas Texas 75204 Recruiting
WISPer Site in Salt Lake City, UT Salt Lake City Utah 84103 Recruiting
WISPer Site in Wilwaukee, WI Milwaukee Wisconsin 52226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06967805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06967805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →